(Q45850089)

16 December 2017

title

Immunotherapy of the rat 13762SC mammary adenocarcinoma by vaccinia virus augmentation of tumor immunity (English)

1 reference

16 December 2017

1 reference

1 reference

vaccinia virus

1 reference

T P Archer

1

1 reference

16 December 2017

P Bretscher

series ordinal

2

1 reference

16 December 2017

B Ziola

series ordinal

3

1 reference

16 December 2017

publication date

1 November 1990

1 reference

16 December 2017

Clinical & Experimental Metastasis

published in

1 reference

16 December 2017

volume

8

1 reference

16 December 2017

issue

6

1 reference

16 December 2017

page(s)

519-532

1 reference

16 December 2017

https://scigraph.springernature.com/pub.10.1007/bf00135875

exact match

0 references

cites work

Feasibility of UV-inactivated vaccinia virus in the modification of tumor cells for augmentation of their immunogenicity

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF00135875

Systemic adoptive transfer of immunity and low-dose irradiation eradicate metastases of 13762A rat mammary adenocarcinoma

21 January 2018

1 reference

12 December 2020

Recombinant vaccinia virus vaccine against the human melanoma antigen p97 for use in immunotherapy

1 reference

12 December 2020

Involvement of soybean agglutinin binding cells in the lymphatic metastasis of the R3230AC rat mammary adenocarcinoma

1 reference

12 December 2020

Phase II study of vaccinia melanoma cell lysates (VMCL) as adjuvant to surgical treatment of stage II melanoma. II. Effects on cell mediated cytotoxicity and leucocyte dependent antibody activity: immunological effects of VMCL in melanoma patients

1 reference

12 December 2020

A 14,000-Mr envelope protein of vaccinia virus is involved in cell fusion and forms covalently linked trimers

1 reference

12 December 2020

A new approach in specific, active immunotherapy

1 reference

12 December 2020

Distinct T-cell proliferative responses to 13762A rat mammary adenocarcinoma and derived clones.

1 reference

12 December 2020

Radiation-induced, immunologically mediated regression of an established tumor as an example of successful therapeutic immunomanipulation. Preferential elimination of suppressor T cells allows sustained production of effector T cells

1 reference

12 December 2020

Establishment of tumor-specific immunotherapy model utilizing vaccinia virus-reactive helper T cell activity

1 reference

12 December 2020

Prevention of syngeneic tumor growth in vaccinia virus-primed mice by immunization with vaccinia virus-modulated tumor cells

1 reference

12 December 2020

Down-regulation of the antitumor immune response.

1 reference

12 December 2020

Concomitant Tumor Immunity and the Resistance to a Second Tumor Challenge

1 reference

12 December 2020

Vaccinia virus proteins on the plasma membranes of infected cells. II. Expression of viral antigens and killing of infected cells by vaccinia virus-specific cytotoxic T cells

1 reference

12 December 2020

Characterization of effector cells mediating antitumor activity in spleen cells of tumor-bearing mice

1 reference

12 December 2020

Virus Augmentation of The Antigenicity of Tumor Cell

1 reference

12 December 2020

Prevention of metastatic spread by postoperative immunotherapy with virally modified autologous tumor cells. I. Parameters for optimal therapeutic effects

1 reference

12 December 2020

Localization at high resolution of antibody-induced mobilization of vaccinia virus hemagglutinin and the major histocompatibility antigens on the plasma membrane of infected cells

1 reference

12 December 2020

Natural killer (NK) cells and their possible roles in resistance against disease

1 reference

12 December 2020

Destruction of regional lymph node metastases of rat mammary adenocarcinoma 13762A by treatment with Corynebacterium parvum

1 reference

12 December 2020

The Murine Antitumor Immune Response and Its Therapeutic Manipulation

1 reference

12 December 2020

Conditions for effective Bacillus Calmette-Guérin immunotherapy of postsurgical metastases of 13762A rat mammary adenocarcinoma

1 reference

12 December 2020

Increased immunogenicity of a spontaneous variant clone of the 13762A rat mammary adenocarcinoma

1 reference

12 December 2020

?-Irradiation facilitates the expression of adoptive immunity against established tumors by eliminating suppressor T cells

1 reference

12 December 2020

Virus-augmented tumor transplantation antigens: evidence for a Helper antigen mechanism

1 reference

12 December 2020

Additional evidence for the augmented induction of tumor-specific resistance in vaccinia virus-primed mice by immunization with vaccinia virus-modulated syngeneic tumor cells.

1 reference

12 December 2020

Prevention of metastatic spread by postoperative immunotherapy with virally modified autologous tumor cells. II. Establishment of specific systemic anti-tumor immunity

1 reference

12 December 2020

Viral antigens act as helper determinants for antibody responses to cell surface antigens

1 reference

12 December 2020

Serologic response to human melanoma lines from patients with melanoma undergoing treatment with vaccinia melanoma oncolysates

1 reference

12 December 2020

Viral oncolysis: increased immunogenicity of host cell antigen associated with influenza virus

1 reference

12 December 2020

Evidence for long-lasting tumor immunity in a syngeneic rat lymphoma model: correlation of in vitro findings with in vivo observations

1 reference

12 December 2020

Vaccinia virus antigens on the plasma membrane of infected cells. I. Viral antigens transferred from infecting virus particles and synthesized after infection

1 reference

12 December 2020

The clonal evolution of tumor cell populations

1 reference

12 December 2020

The augmentation of tumor-specific immunity by virus help. II. Enhanced induction of cytotoxic T lymphocyte and antibody responses to tumor antigens by vaccinia virus-reactive helper T cells

1 reference

12 December 2020

Characteristics of T cells involved in the expression of delayed hypersensitivity and tumor rejection immunity to 13762A rat mammary adenocarcinoma

1 reference

12 December 2020

Identification of antigenic determinants by polyclonal and hybridoma antibodies induced during the course of infection by vaccinia virus

1 reference

12 December 2020

Circulating immune complexes and immunoglobulin M-class rheumatoid factor in rats bearing mammary adenocarcinomas which vary in ability to metastasize

1 reference

12 December 2020

T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00135875

1 reference

16 December 2017

Dimensions Publication ID

1003139696

0 references

1 reference

16 December 2017